Menopause Hormone Therapy (HRT) in East Orange, NJ

Bioidentical hormones in East Orange: what it means

"Bioidentical" describes a hormone whose chemical structure matches one the body makes. Two hormones used in menopause care fit it exactly, estradiol and micronized progesterone. Both come in FDA-approved prescription forms, from estradiol pills, patches, gels and vaginal forms to progesterone capsules.

Only 4 OB-GYNs list a primary practice address in East Orange in the NPI registry. For 69,183 residents that is 5.8 per 100,000, under the US 17.8 and below New Jersey's 19.9. Set against the city's 9,839 women aged 45 to 64, that is one OB-GYN for roughly every 2,460.

Counting the area around it, 387 OB-GYNs practice in East Orange or within 10 miles and 3,243 within 25 miles: 23.7 for every 100,000 of the 13,704,686 people who live within 25 miles, a dense supply. VevaMD is an online option alongside them: a physician licensed in New Jersey reviews your intake from East Orange without an office visit, and an OB-GYN you already see stays your doctor.

"BHRT" often means compounded hormones, a cream, a blend such as Bi-Est or a pellet that a pharmacy mixes for one prescription. They are not FDA-approved, which means the FDA cannot assure their safety or effectiveness. The FDA also says it has no evidence that they are safe and effective, or more effective than approved hormone therapy. A 2020 National Academies review found no rigorous evidence of their safety and effectiveness.

For women in East Orange, a physician licensed in New Jersey can prescribe estradiol (pill, patch, cream or vaginal) and progesterone when they fit your history. There are no pellets. Because the dispensing pharmacy also compounds, you can ask whether your estradiol or progesterone is an FDA-approved product. Two options are compounded for certain: testosterone cream for women and Bi-Est are not FDA-approved.

A pellet clinic is a different model: it implants a hormone pellet under the skin during a visit, and compounded pellets are not FDA-approved. The Endocrine Society points to a study that found hormone levels well above the expected range in women using them. ACOG recommends FDA-approved menopause hormone therapy over compounded hormones.

Sources: FDA: Menopause · FDA: National Academies study of compounded bioidentical hormones (2020) · Endocrine Society position statement on compounded bioidentical hormones (2019) · ACOG Clinical Consensus No. 6, compounded bioidentical menopausal hormone therapy (2023) · CMS NPPES NPI full file, 2026-10-11